Company Filing History:
1 out of 38 
1 out of 6 
1 out of 8 Years Active: 2019
Title: Beatriz Llamusi Troísi: Innovator in Myotonic Dystrophy Treatment
Introduction
Beatriz Llamusi Troísi is a prominent inventor based in València, Spain. She has made significant contributions to the field of medical research, particularly in the treatment of myotonic dystrophy. Her innovative work has led to the development of a unique compound aimed at addressing this challenging condition.
Latest Patents
Beatriz holds a patent for "Compounds for the treatment of myotonic dystrophy." This invention relates to a compound of formula (I), which is not caffeine, intended for use in treating myotonic dystrophy types 1 and 2. The patent also encompasses compositions that include this compound and introduces new compounds that are dimers of the original formula.
Career Highlights
Throughout her career, Beatriz has been associated with esteemed institutions such as Universitat de València and Institut Químic de Sarria CETS Fundació Privada. Her work in these organizations has been instrumental in advancing research in her field.
Collaborations
Beatriz has collaborated with notable colleagues, including Ruben Artero Allepuz and Josep Castells Boliart. These partnerships have enriched her research and contributed to her innovative endeavors.
Conclusion
Beatriz Llamusi Troísi is a trailblazer in the field of medical innovation, particularly in the treatment of myotonic dystrophy. Her contributions through her patent and collaborations highlight her commitment to advancing healthcare solutions.